PhD Programme in Experimental Medicine and Therapy - Dottorato in Medicina e Terapia Sperimentale

Selected research products

Calcagno, A, Cusato, J, Marinaro, L, Trentini, L, Alcantarini, C, Mussa, M, Simiele, M, D', Avolio, A, Di Perri, G, Bonora, S (2016)
Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines.
https://iris.unito.it/handle/2318/1618847

Boglione, Lucio, De Nicolò, Amedeo, Cusato, Jessica, Bonifacio, Gabriele, Cariti, Giuseppe, Di Perri, Giovanni, D', Avolio, Antonio (2016)
Entecavir plasma concentrations are inversely related to HBV-DNA decrease in a cohort of treatment-naïve patients with chronic hepatitis B.
https://iris.unito.it/handle/2318/1615143

Cusato, Jessica, Allegra, Sarah, De Francia, Silvia, Massano, Davide, Piga, Antonio, D', Avolio, Antonio (2016)
Role of pharmacogenetics on deferasirox AUC and efficacy.
https://iris.unito.it/handle/2318/1618840

Allegra, Sarah, De Francia, Silvia, Cusato, Jessica, Pirro, Elisa, Massano, Davide, Piga, Antonio, D', Avolio, Antonio (2016)
Deferasirox pharmacokinetic and toxicity correlation in ?-thalassaemia major treatment.
https://iris.unito.it/handle/2318/1615142

Galimberti, S , Galeotti, L , Ceccherini, F , Domingo, D , Laurino, M , Barate, C , Ricci, F , Grassi, S , Guerrini, F , Fava, C , D', Avolio, A , Cervetti, G , Fontanelli, G , Saglio, G , Cornolti, F , Petrini, M , Arrigoni, E , Di Paolo, A (2016)
THE HOCT1/ABCB1 DIPLOTYPE IS ASSOCIATED WITH COMPLETE CYTOGENETIC RESPONSE AND TOLERABILITY TO IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA.
https://iris.unito.it/handle/2318/1609196

Scaviglieri, E , Cusato, J , Audagnotto, S , Lipani, F , Cardellino, C , Cecilia, C , D', Avolio, A , Bonora, S , Di Perri, G , Calcagno, A (2016)
Pharmacogenetics of Antiretrovirals' Penetrations into Cerebrospinal Fluid.
https://iris.unito.it/handle/2318/1565197

Boglione, Lucio, Cusato, Jessica, Cariti, Giuseppe, D', Avolio, Antonio, Di Perri, Giovanni (2016)
Ruolo della riduzione precoce di HBsAg per individuare i pazienti con infezione precoce da HBV, HBeAg-negativi e genotipo E ad alta probabilità di risposta sostenuta con 48 settimane di trattamento con PEG-INF ALFA-2A.
https://iris.unito.it/handle/2318/1609094

D', Avolio, Antonio, Cusato, Jessica, De Nicolò, Amedeo, Allegra, Sarah, Di Perri, Giovanni (2016)
Pharmacogenetics of ribavirin-induced anemia in HCV patients.
https://iris.unito.it/handle/2318/1618789

Antonio D', Avolio (2016)
Il dosaggio dei farmaci immunosoppressori: tecnologie a confronto.
https://iris.unito.it/handle/2318/1615916

Calcagno, Andrea, Cusato, Jessica, D', Avolio, Antonio, Bonora, Stefano (2016)
Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs.
https://iris.unito.it/handle/2318/1618816

Allegra, Sarah, De Francia, Silvia, Longo, Filomena, Massano, Davide, Cusato, Jessica, Arduino, Arianna, Pirro, Elisa, Piga, Antonio, D', Avolio, Antonio (2016)
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous ?-thalassaemia.
https://iris.unito.it/handle/2318/1618799

Boglione, Lucio, Cusato, Jessica, Cariti, Giuseppe, Di Perri, Giovanni, D', Avolio, Antonio (2016)
Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferon.
https://iris.unito.it/handle/2318/1615144

Boglione, Lucio, Nicolò, Amedeo De, Pinna, Simone Mornese, Cusato, Jessica, Cariti, Giuseppe, D', Avolio, Antonio, Di Perri, Giovanni (2016)
Influenza della somministrazione del metadone sulle concentrazioni plasmatiche di daclatasvir in una coorte di pazienti con epatite cronica da HCV e tossicodipendenza attiva.
https://iris.unito.it/handle/2318/1609093

Boglione, Lucio, Cariti, Giuseppe, Di Perri, Giovanni, D', Avolio, Antonio (2016)
Sequential therapy with entecavir and pegylated interferon in a cohort of young patients affected by chronic hepatitis B.
https://iris.unito.it/handle/2318/1620349

Marinaro, Letizia, Calcagno, Andrea, Ripamonti, Diego, Cenderello, Giovanni, Pirriatore, Veronica, Trentini, Laura, Salassa, Bernardino, Bramato, Caterina, Orofino, Giancarlo, D', Avolio, Antonio, Rizzi, Marco, Di Perri, Giovanni, Rusconi, Stefano, Bonora, Stefano (2016)
Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting.
https://iris.unito.it/handle/2318/1621597

Cusato, Jessica, Allegra, Sarah, Boglione, Lucio, De Nicolò, Amedeo, Cariti, Giuseppe, Di Perri, Giovanni, D?Avolio, Antonio (2015)
VDR gene polymorphisms impact on anemia at 2 week of anti-HCV therapy: a possible mechanism for early RBV-induced anemia.
https://iris.unito.it/handle/2318/1539152

Simiele, Marco, Pensi, Debora, Pasero, Daniela, Ivaldi, Francesca, Rinaldi, Mauro, Di Perri, Giovanni, Ranieri, Vito Marco, D', Avolio, Antonio (2015)
Development and validation of an ultra performance liquid chromatography tandem mass method for sildenafil and N-desmethyl sildenafil plasma determination and quantification.
https://iris.unito.it/handle/2318/1563753

Abdelhafez, A, Cusato, J, Hussein, A, Kamel, S, De Nicolo', , A, Di Perri, G, D', Avolio, A, El Desoky, E (2015)
ITPA gene variants as markers of ribavirin-induced anemia and white blood cells reduction in Egyptian HCV patients.
https://iris.unito.it/handle/2318/1528192

Calcagno A, Simiele M, Alberione MC, Bracchi M, Marinaro L, Ecclesia S, Di Perri G, D', Avolio A, Bonora S (2015)
Cerebrospinal Fluid Inhibitory Quotients of Antiretroviral Drugs in HIV-positive Patients are Associated with Compartmental Viral Control.
https://iris.unito.it/handle/2318/158854

Cillo, U, Burra, P, Mazzaferro, V, Belli, L, Pinna, Ad, Spada, M, Nanni Costa, A, Toniutto, P, Avolio, A, Cescon, M, Romagnoli, R, Santaniello, W, Rossi, M, Corno, V, Caraceni, P, Coco, B, Fraquelli, M, Rendina, M, Angelico, M, Fagiuoli, S, Bruno, R, Costa, An, Ridol?, L, R,, Pretagostini, R, Amoroso, A, Bianco?ore, G, De Gasperi, A, Rocca, Gd, Feltracco, P, Colli, A, Sacchini, D, Pegoraro, R, Gardini, I, Pipit, P, Maffeo, C, Rossellini, Sr (2015)
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "Blended Principle Model".
https://iris.unito.it/handle/2318/1565693

Cusato J, Allegra S, Boglione L, De Nicolò A, Baietto L, Cariti G, Di Perri G, D', Avolio A (2015)
Vitamin D pathway gene variants and HCV-2/3 therapy outcomes.
https://iris.unito.it/handle/2318/1506302

Milazzo L, Peri AM, Mazzali C, Magni C, Calvi E, De Nicolò A, Clementi E, Cheli S, D', Avolio A, Antinori S, Falvella FS (2015)
SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir.
https://iris.unito.it/handle/2318/1507941

Avolio, A , Cardella, S , Fagiuoli, S , Spada, M , De Feo, T , Amoroso, A , Lirosi, M C , Rizza, G , Lucà, M G , Bonsignore, P , Spagnoletti, G , Tandoi, F , Dibenedetto, C , Saffioti, M C , Bertinetto, F , Piccolo, G , Gasbarrini, A , Agnes, S , Colledan, M , Salizzoni, M , Romagnoli, R (2015)
RANK OF SURVIVAL BENEFIT, AS A PROPOSED PRIORITY SYSTEM, IN LIVER TRANSPLANT WAITING LIST: EVIDENCES FROM AN ITALIAN MULTICENTRE COHORT STUDY.
https://iris.unito.it/handle/2318/1612007

Avolio, A W , Cardella, S , Fagiuoli, S , Spada, M , De Feo, T , Amoroso, A , Lirosi, M C , Rizza, G , Luca', , M G , Bonsignore, P , Spagnoletti, G , Tandoi, F , Dibenedetto, C , Saffioti, M C , Piccolo, G , Agnes, S , Colledan, M , Salizzoni, M , Romagnoli, R (2015)
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study.
https://iris.unito.it/handle/2318/1612069

Galimberti, S, Galeotti, L, Ceccherini, F, Domingo, D, Laurino, M, Polillo, M, Di Paolo, A, Barate, C, Fava, C, D', Avolio, A, Fontanelli, G, Danesi, R, Cornolti, F, Guerrini, F, Ciabatti, E, Saglio, G, Petrini, M (2015)
Combined Famd and ANOVA Investigation Leads to Significant Association Between the hOCT1/ABCB1 Diplotype and Both Efficacy and Tolerability in Patients Affected By Chronic Myeloid Leukemia.
https://iris.unito.it/handle/2318/1614620

Baietto L, D', Avolio A, Cusato J, Pace S, Calcagno A, Motta I, Corcione S, Di Perri G, De Rosa FG (2015)
Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients.
https://iris.unito.it/handle/2318/1506190

De Nicolò, Amedeo, Abdi, Adnan Mohamed, Boglione, Lucio, Baietto, Lorena, Allegra, Sarah, Di Perri, Giovanni, D', Avolio, Antonio (2015)
UPLC-MS/MS method with automated on-line SPE for the isomer-specific quantification of the first-generation anti-HCV protease inhibitors in peripheral blood mononuclear cells.
https://iris.unito.it/handle/2318/1563696

D', Avolio A, Carcieri C, Cusato J, Simiele M, Calcagno A, Allegra S, Sciandra M, Trentini L, Di Perri G, Bonora S (2014)
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms.
https://iris.unito.it/handle/2318/154852

De Nicolò A, Agnesod D, Simiele M, Riganò D, Adriani A, Canaparo R, Astegiano M, Rizzetto M, Di Perri G, D', Avolio A (2014)
UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells.
https://iris.unito.it/handle/2318/148135

Boglione L, Cardellino CS, De Nicolò A, Cariti G, Di Perri G, D', Avolio A (2014)
Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E.
https://iris.unito.it/handle/2318/149194

D', Avolio A, Pensi D, Baietto L, Di Perri G (2014)
Therapeutic drug monitoring of intracellular anti-infective agents.
https://iris.unito.it/handle/2318/149665

A De Nicolò, A Ciancio, L Boglione, A Mohamed Abdi, A Smedile, G P Caviglia, G Di Perri, M Rizzetto, A D?Avolio (2014)
The co-administration of telaprevir increases ribavirin plasma and intra-erythrocytic concentrations, causing higher onset of anemia.
https://iris.unito.it/handle/2318/142535

Nozza S, Bigoloni A, Calcagno A, Galli L, Pignataro AR, D', Avolio A, Carbone A, Ripa M, Bonora S, Lazzarin A, Castagna A (2014)
Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection.
https://iris.unito.it/handle/2318/143536

De Francia S, D?avolio A, Ariaudo A, Pirro E, Piccione F, Simiele M, Fava C, Calcagno A, Di Perri G, Saglio G (2014)
Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia.
https://iris.unito.it/handle/2318/145080

Tempestilli M, Elisei F, Cimini E, D', Avolio A, Grassi G, Nicastri E, Narciso P, Martini F, Alonzi T, Paolo Pucillo L (2014)
Low-density lipoprotein and ritonavir: an interaction between antiretrovirals and lipids mediated by P-glycoprotein.
https://iris.unito.it/handle/2318/147789

Boglione L, Cusato J, Cariti G, Di Perri G, D', Avolio A (2014)
The E genotype of hepatitis B: Clinical and virological characteristics, and response to interferon.
https://iris.unito.it/handle/2318/145081

De Nicolò A, Boglione L, Ciancio A, Cusato J, Strona S, Cardellino CS, Abdi AM, Cariti G, Troshina G, Caviglia GP, Smedile A, Rizzetto M, Di Perri G, D', Avolio A (2014)
Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner.
https://iris.unito.it/handle/2318/147801

Boglione L, Cusato J, De Nicolò A, Cariti G, Allegra S, Ghisetti V, Perri GD, D', Avolio A (2014)
Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms.
https://iris.unito.it/handle/2318/144151

GK Jagjit Singh, A Jackson, A D?Avolio, L Else, S Bonora, G Di Perri, S Khoo, D Back, G Moyle, M Boffito (2014)
Pharmacokinetics (PK) of the co-administration of raltegravir (RAL) and amlodipine (AML) to male and female healthy volunteers.
https://iris.unito.it/handle/2318/143613

Agnesod D, De Nicolò A, Simiele M, Mohamed Abdi A, Boglione L, Di Perri G, D', Avolio A (2014)
Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients.
https://iris.unito.it/handle/2318/141613

A De Nicolò, A Ciancio, L Boglione, A Mohamed Abdi, A Smedile, G P Caviglia, G DI Perri, M Rizzetto, A D', Avolio (2014)
A concentration-dependent pharmacokinetic interaction with telaprevir increases ribavirin concentrations and leads to higher haemoglobin drop.
https://iris.unito.it/handle/2318/145371

Baietto L, Corcione S, Pacini G, Di Perri G, D', Avolio A, De Rosa FG (2014)
A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
https://iris.unito.it/handle/2318/154851

Fanelli V, Costamagna A, Persico P, Rotondo G, Mascia L, Corcione S, Baietto L, D', Avolio A, Terragni PP, De Rosa FG, Bonato R, Del Sorbo L, Boffini R, Rinaldi M, Ranieri VM (2014)
PHISIOLOGIC VARIABLES AND PHARMCOKINETICS IMIPENEM DURING ENLP. A SINGLE CENTER TRANSPLANTATION EXPERIENCE.
https://iris.unito.it/handle/2318/150045

Ariaudo A, Simiele M, Calcagno A, Bonora S, Di Perri G, D', Avolio A (2014)
Intracellular accumulation of the new integrase inhibitors elvitegravir and dolutegravir in HIV patients.
https://iris.unito.it/handle/2318/149189

Fava C, Cusato J, Ariaudo A, D', Avolio A, De Francia S, Giugliano E, Rege-Cambrin G, Saglio G (2014)
PHARMACOGENETIC DETERMINANTS OF PLASMATIC AND INTRACELLULAR TYROSINE KINASE INHIBITORS.
https://iris.unito.it/handle/2318/150046

Pallotto C, Fiorio M, D', Avolio A, Sgrelli A, Baldelli F, Di Perri G, De Socio GV (2014)
Cerebrospinal fluid penetration of tigecycline.
https://iris.unito.it/handle/2318/141158

Baietto L, Simiele M, D', Avolio A (2014)
How effective are the use of DBS and DPS as tools to encourage widespread therapeutic drug monitoring?
https://iris.unito.it/handle/2318/142306

Calvo PL, Pinon M, Canaparo R, D?Avolio A, Brunati A, Pensi D, De Nicolò A, Carbonaro G, Cerrina A, Nonnato A, Romagnoli R, Barbera C, Salizzoni M (2014)
Pharmacokinetic and pharmacogenetic analysis of tacrolimus in pediatric liver transplant patients in the early post-liver transplantation period.
https://iris.unito.it/handle/2318/155426

Pinon M, Calvo PL, D?Avolio A, Pensi D, Brunati A, Canaparo R, De Nicolò A, Carbonaro G, Cerrina A, Di Perri G, Romagnoli R, Barbera C, Salizzoni M (2014)
Quantification of tacrolimus in PBMCs samples in pediatric liver transplant patients and correlation with tacrolimus whole blood concentration.
https://iris.unito.it/handle/2318/155424

M Tempestilli, F Elisei, E Cimini, A D?Avolio, E Nicastri, F Martini, T Alonzi, L P Pucillo (2014)
Interaction between Ritonavir and Low Density Lipoprotein could explain drug failure and increase of atherosclerosis risk.
https://iris.unito.it/handle/2318/144162

Baietto L, D', Avolio A, Pace S, Simiele M, Marra C, Ariaudo A, Di Perri G, Rosa FG (2014)
Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots.
https://iris.unito.it/handle/2318/138855

Calcagno A, Cusato J, Simiele M, Motta I, Audagnotto S, Bracchi M, D', Avolio A, Di Perri G, Bonora S (2014)
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis.
https://iris.unito.it/handle/2318/140932

De Rosa FG, Motta I, Corcione S, Cattel F, Di Perri G, D', Avolio A (2014)
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines.
https://iris.unito.it/handle/2318/149192

Cristina Tomasello, Jessica Cusato, Anna Leggieri, Stefano Bonora, Giovanni Di Perri, Antonio D', Avolio (2013)
Descrittiva della farmacocinetica (PK) e della farmacogenetica (PG) dell'Efavirenz in una coorte di popolazione italiana.
https://iris.unito.it/handle/2318/138716

C Tomasello, MM Giacomotti, A D?Avolio, M Simiele, A Leggieri, G Di Perri (2013)
TCH-042 Stability Study of Ganciclovir in 0.9% Sodium Chloride in Different Types of Containers: Optimization of Resources.
https://iris.unito.it/handle/2318/127416

D', Avolio A, De Francia S, Basile V, Cusato J, De Martino F, Pirro E, Piccione F, Ardito A, Zaggia B, Volante M, Di Perri G, Terzolo M (2013)
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane.
https://iris.unito.it/handle/2318/132522

Neijen RW, van Maarseveen EM, Wensing AMJ, Bonora S, D', Avolio A, Hoepleman AI, Mudrikova T (2013)
Continuous intravenous infusion of enfuvirtide in an out-clinic patient with a multi resistent HIV strain and severe injection-site reactions.
https://iris.unito.it/handle/2318/131484

C Montrucchio, A Calcagno, M Lanzafame, G Cenderello, M Simiele, MC Tettoni, P Bigliano, A D?Avolio, G Di Perri, S Bonora (2013)
Pharmacokinetics of the Dual NRTI- and Protease Inhibitor-sparing Regimen Raltegravir plus Nevirapine in HIV-1+ Patients.
https://iris.unito.it/handle/2318/133959

Antonio D', Avolio, Amedeo De Nicolò, Marco Simiele, Lorena Baietto, Andrea Calcagno, Mauro Sciandra, Laura Trentini, Cristina Tettoni, Letizia Marinaro, Giovanni Di Perri, Stefano Bonora (2013)
Could ritonavir intracellular concentrations have a role as active drugs when used as a booster PIs?
https://iris.unito.it/handle/2318/132525

M Tempestilli, F Elisei, E Cimini, T Alonzi, A D?Avolio, E Nicastri, F Martini, L P Pucillo (2013)
Low density lipoprotein level may affect the intracellular concentration of antiretroviral drugs.
https://iris.unito.it/handle/2318/134013

L Marinaro, A Calcagno, D Ripamonti, G Cenderello, V Pirriatore, L Trentini, B Salassa, C Bramato, G Orofino, A D?Avolio, G Di Perri, S Rusconi, S Bonora (2013)
Efficacy, Safety and Pharmacokinetics of Atazanavir (200 mg twice-daily) plus Raltegravir (400 mg twice-daily) Dual Regimen in the Clinical Setting.
https://iris.unito.it/handle/2318/134081

Silvia De Francia, Vittoria Basile, Antonio D', Avolio, Francesca De Martino, Elisa Pirro, Arianna Ardito, Francesca Piccione, Jessica Cusato, Massimo Terzolo (2013)
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients.
https://iris.unito.it/handle/2318/130890

D', Avolio A, Simiele M, Calcagno A, Siccardi M, Larovere G, Agati S, Baietto L, Cusato J, Tettoni M, Sciandra M, Trentini L, Di Perri G, Bonora S (2013)
Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells.
https://iris.unito.it/handle/2318/129094

S Nozza, A Bigoloni, L Galli, A Calcagno, A R Pignataro, A D?Avolio, A Carbone, M Ripa, S Bonora, A Lazzarin, A Castagna (2013)
Viral rebound after switch to Maraviroc-Raltegravir dual therapy.
https://iris.unito.it/handle/2318/134261

L Marinaro, A Calcagno, S Nozza, C Aldieri, A Bigoloni, V Ghisetti, A Trentalange, T Allice, P Bigliano, A D?Avolio, G Di Perri, A Castagna, S Bonora (2013)
Etravirine Plasma Exposure is Associated with virological Response in Experienced HIV-positive Patients.
https://iris.unito.it/handle/2318/134012

A Calcagno, J Cusato, M Simiele, R Bertucci, S Raviolo, L Marinaro, M C Tettoni, A Trentalange, C Alcantarini, A D?Avolio, G Di Perri, S Bonora (2013)
High Interpatient Variability of Raltegravir Cerebrospinal Fluid Concentrations in HIV-positive Patients: a Pharmacogenetic Analysis.
https://iris.unito.it/handle/2318/132683

Calcagno A, Gonzalez de Requena D, Simiele M, D', Avolio A, Tettoni M, Salassa B, Orofino G, Bramato C, Libanore V, Motta I, Bigliano P, Orsucci E, Di Perri G, Bonora S (2013)
Tenofovir Plasma Concentrations According to Companion Drugs: a Cross-sectional Study in HIV-positive Patients with Normal Renal Function.
https://iris.unito.it/handle/2318/127338

Amedeo De Nicolò, Jessica Cusato, Lucio Boglione, Francesca Patti, Alessia Ciancio, Antonina Smedile, Danilo Agnesod, Giuseppe Cariti, Mario Rizzetto, Giovanni Di Perri, Antonio D', Avolio (2013)
Early ribavirin concentration is a critical response factor in the sub-population of patients infected by HCV-1 and unfavourable IL28B genotype.
https://iris.unito.it/handle/2318/132524

Amedeo De Nicolò, Jessica Cusato, Lucio Boglione, Alessia Ciancio, Antonina Smedile, Danilo Agnesod, Giuseppe Cariti, Mario Rizzetto, Giovanni Di Perri, Antonio D', Avolio (2013)
Early ribavirin plasma concentrations as predictor of anemia onset after one month of anti-HCV therapy in ITPA stratified population.
https://iris.unito.it/handle/2318/131620

D', Avolio A, De Nicolò A, Agnesod D, Simiele M, Mohamed Abdi A, Dilly Penchala S, Boglione L, Cariti G, Di Perri G (2013)
A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir.
https://iris.unito.it/handle/2318/37825

Boglione L, D', Avolio A, Cariti G, Milia MG, Simiele M, De Nicolò A, Ghisetti V, Di Perri G (2013)
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes.
https://iris.unito.it/handle/2318/43461

Boglione L, D', Avolio A, Cariti G, Di Perri G (2013)
Telbivudine in the treatment of hepatitis B-associated cryoglobulinemia.
https://iris.unito.it/handle/2318/127337

Calcagno A, Yilmaz A, Cusato J, Simiele M, Bertucci R, Siccardi M, Marinaro L, D', Avolio A, Di Perri G, Bonora S (2012)
Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics.
https://iris.unito.it/handle/2318/126764

Baietto L, G De Rosa F, D?avolio A, Marra C, Pace S, Biasin E, Carraro F, Nesi F, Simiele M, Cusato J, Siccardi M, Di Perri G (2012)
Prophylactic drug monitoring of itraconazole in an oncohematological pediatric patient population.
https://iris.unito.it/handle/2318/122218

Baietto L, D', Avolio A, Marra C, Simiele M, Cusato J, Pace S, Ariaudo A, De Rosa FG, Di Perri G (2012)
Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS.
https://iris.unito.it/handle/2318/122364

KJ Ibrahim, E Sigaudo, A D?Avolio, M Fadda, P Caviglia, A Smedile, G DiPerri, M Rizzetto (2012)
F-8 Importance of HLA-B in the sustained virological response in patients with chronic hepatitis C treated with peg-IFN and ribavirin.
https://iris.unito.it/handle/2318/126433

Antonio D', Avolio, Silvia De Francia, Alessandra Ariaudo, Marco Simiele, Jessica Cusato, Carmen Fava, Lorena Baietto, Giovanni Di Perri, and Giuseppe Saglio (2012)
Single-Nucleotide Polymorphisms of ABCB1 Gene Influence Intracellular Concentrations of Dasatinib.
https://iris.unito.it/handle/2318/157327

GP Caviglia, A D', Avolio, A Ciancio, A De Nicolò, L Boglione, ML Abate, C Rosso, A Smedile, G Cariti, J Cusato, M Simiele, M Rizzetto, G Di Perri (2012)
F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy.
https://iris.unito.it/handle/2318/126432

Burlone ME, Minisini R, D', Avolio A, Ciancio A, Franzosi L, Naturale C, Cusato J, Smedile A, Rizzetto M, Di Perri G, Pirisi M (2012)
Discordant results for IL28B genotyping (rs12979860 vs. rs8099917) and the prediction of rapid viral response in chronic hepatitis C.
https://iris.unito.it/handle/2318/128239

A D?Avolio, A Ciancio, M Siccardi, A Smedile, L Baietto, M Simiele, D A Marucco, G Cariti, A Calcagno, D G de, M Sciandra, J Cusato, G Troshina, S Bonora, M Rizzetto, G D Perri (2012)
Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment.
https://iris.unito.it/handle/2318/110741

S Bonora, A Calcagno, C Cometto, S Fontana, D Aguilar, A D', Avolio, D G de, A Maiello, I D Conte, A Lucchini, G D Perri (2012)
Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study.
https://iris.unito.it/handle/2318/116627

Calcagno A, Gonzalez de Requena D, Simiele M, D?Avolio A, Tettoni MC, Salassa B, Orofino G, Libanore V, Di Perri G, Bonora S (2012)
Determinants of Tenofovir Plasma Trough Concentrations: a Cross-sectional Analysis in the Clinical Setting.
https://iris.unito.it/handle/2318/112064

De Rosa FG, D', Avolio A, Corcione S, Baietto L, Raviolo S, Centofanti P, Pasero D, Rinaldi M, Di Perri G (2012)
Anidulafungin for Candida glabrata Infective Endocarditis.
https://iris.unito.it/handle/2318/119749

D', Avolio Antonio (2012)
Il ruolo del polimorfismo genetico nel metabolismo di ribavirina.
https://iris.unito.it/handle/2318/41920

Brizzi MP, Fazio N, Ferrero A, Nobili E, Volante M, Tozzi L, D', Avolio A, Milanesi E, Dogliotti L, Berruti A (2012)
Bevacizumab Plus Octreotide and Metronomic Capecitabine in Patients with Metastatic Well-to-Moderately Differentiated Neuroendocrine Tumors. The XELBEVOCT Multicenter Phase II Study.
https://iris.unito.it/handle/2318/125232

Boglione L, D', Avolio A, Cariti G, Gregori G, Burdino E, Baietto L, Cusato J, Ghisetti V, De Rosa FG, Perri GD (2012)
Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.
https://iris.unito.it/handle/2318/127414

Calcagno A, Bonora S, Tettoni MC, Bonasso M, Salassa B, Orofino G, Bramato C, Trentini L, Simiele M, Marinaro L, Bertucci R, Imperiale D, D', Avolio A, Ghisetti V, Di Perri G (2011)
MONITORING OF VIROLOGICAL AND PHARMACOLOGICAL CEREBROSPINAL FLUID PARAMETERS IN HAART-TREATED HIV-POSITIVE PATIENTS IN THE CLINICAL SETTING.
https://iris.unito.it/handle/2318/97352

Calcagno A , Bonora S , Simiele M , Audagnotto S , Siccardi M , de Requena D Gonzalez, Romito A , Imperiale D , D', Avolio A , Di Perri G (2011)
TENOFOVIR AND EMTRICITABINE CSF-TO-PLASMA RATIOS CORRELATE TO THE EXTENT OF BLOOD BRAIN-BARRIER DAMAGE.
https://iris.unito.it/handle/2318/98624

S Corcione, A Calcagno, S Bonora, A D', Avolio, S , Ferrando, M Vassallo, S Nozza, A Castagna, P , Dellamonica, R Garraffo, G Di Perri (2011)
Clinical pharmacology of complex regiment of antiretroviral therapy including Etravirine, Maraviroc and Raltégravir.
https://iris.unito.it/handle/2318/95875

A Calcagno, S Nozza, S Bonora, A Castagna, D G de, A D', Avolio, A Lazzarin, G D Perri (2011)
Pharmacokinetics of the raltegravir/maraviroc/etravirine combination.
https://iris.unito.it/handle/2318/96912

A Jackson, A D', Avolio, V Watson, S Bonora, D Back, J Taylor, K Armenis, B Gazzard, G Moyle, M Boffito (2011)
Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers.
https://iris.unito.it/handle/2318/98489

D', Avolio A , Simiele M , Siccardi M , Baietto L , Agati S , Cusato J , Calcagno A , Tettoni M , Trentini L , Bonora S , Di Perri G (2011)
INTRACELLULAR ACCUMULATION OF RITONAVIR ASSOCIATED WITH DIFFERENT BOOSTED PIS.
https://iris.unito.it/handle/2318/98518

Silvia De Francia, Francesca De Martino, Antonio D', Avolio, Elisa Pirro, Francesca Piccione, Jessica Cusato, Alfredo Berruti, Massimo Terzolo, Francesco Di Carlo (2011)
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients.
https://iris.unito.it/handle/2318/105144

M Simiele, A D', Avolio, L Baietto, M Siccardi, M Sciandra, S Agati, J Cusato, S Bonora, G D Perri (2011)
Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations.
https://iris.unito.it/handle/2318/97046

Antonio D', Avolio, Marco Siccardi, Jessica Cusato, Marco Simiele, Lorena Baietto, Andrea Calcagno, Mauro Sciandra, Stefano Bonora, Giovanni Di Perri (2011)
Single-nucleotide polymorphism PXR 7635G>A influences plasma concentrations of Efavirenz in CYP2B6 516G>T carriers.
https://iris.unito.it/handle/2318/95872

C Tommasi, R Bellagamba, M Tempestilli, A D', Avolio, A L Gallo, J Ivanovic, E Nicastri, L P Pucillo, P Narciso (2011)
Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis.
https://iris.unito.it/handle/2318/96913

J Ashby, L Garvey, O W Erlwein, H Lamba, R Weston, K Legg, N Latch, M O McClure, L Dickinson, A D', Avolio, D Back, A Winston (2011)
Pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers.
https://iris.unito.it/handle/2318/96994

D G de, S Bonora, O Viganò, A Calcagno, C Cometto, A D', Avolio, L Baietto, V Ghisetti, S Magnani, S Ferramosca, P Vitiello, M Galli, S Rusconi, G D Perri (2011)
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens.
https://iris.unito.it/handle/2318/98583

Calcagno A, Bonora S, Simiele M, Rostagno R, Tettoni MC, Bonasso M, Romito A, Imperiale D, D', Avolio A, Di Perri G (2011)
Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage.
https://iris.unito.it/handle/2318/96179

Garazzino S, Aprato A, Baietto L, D', Avolio A, Maiello A, De Rosa FG, Aloj D, Siccardi M, Biasibetti A, Massè A, Di Perri G (2011)
Ceftriaxone bone penetration in patients with septic non-union of the tibia.
https://iris.unito.it/handle/2318/96960

S Bonora, D G de, A D', Avolio, A Calcagno, M Tettoni, M Siccardi, L Baietto, M Simiele, L Trentini, G D Perri (2011)
Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients.
https://iris.unito.it/handle/2318/95548

A D', Avolio, M Simiele, M Siccardi, L Baietto, M Sciandra, V Oddone, F R Stefani, S Agati, J Cusato, S Bonora, G D Perri (2011)
A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.
https://iris.unito.it/handle/2318/96961

D', Avolio A, Ciancio A, Siccardi M, Baietto L, Simiele M, Cariti G, Calcagno A, Smedile A, Cusato J, Bonora S, Rizzetto M, Di Perri G (2011)
Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4.
https://iris.unito.it/handle/2318/94406

Calcagno A, Bonora S, D', Avolio A, Siccardi M, Sciandra M, Simiele M, Baietto L, Di Perri G (2010)
Undetectable Ritonavir Plasma Concentrations in Different Boosted PI-based Regimens as a Marker of Non-Adherence: analysis of a large TDM Registry.
https://iris.unito.it/handle/2318/84456

Antonio D', Avolio, Marco Siccardi, Marco Simiele, Lorena Baietto, Silvia Agati, Andrea Calcagno, Mauro Sciandra, Stefano Bonora, Giovanni Di Perri (2010)
Single-nucleotide polymorphisms ABCB1 3435C>T, 1236C>T and CYP2B6 516G>T influence plasma concentrations of Efavirenz (EFV).
https://iris.unito.it/handle/2318/87542

A Calcagno, R Rostagno, S Audagnotto, A D', Avolio, S Bonora, V Ghisetti, G D Perri (2010)
Is peritoneal fluid a sanctuary site for HIV?
https://iris.unito.it/handle/2318/81770

Antonio D', Avolio, Alessia Ciancio, Marco Siccardi, Lorena Baietto, Marco Simiele, Samantha Patanella, Diego Aguilar Marucco, Giuseppe Cariti, Andrea Calcagno, Mauro Sciandra, Antonina Smedile, Francesco Giuseppe De Rosa, Stefano Bonora, Mario Rizzetto, Giovanni Di Perri (2010)
SLC28A2 65C>T predict Sustained Virological Response in patients with hepatitis C treated with interferon and ribavirin, considering all HCV genotype and genotype 1/4.
https://iris.unito.it/handle/2318/95236

Calcagno A, Bonora S, Lucchini A, Maiello A, Dal Conte I, Gonzalez de Requena D, D?Avolio A, Siccardi M, Di Perri G (2010)
Pharmacokinetic Determinants of Immunovirological Response in HIV Very Late Presenters.
https://iris.unito.it/handle/2318/83256

Calcagno A, Bonora S, Gonzalez De Requena D, Nozza S, D?Avolio A, Siccardi M, Simiele M, Castagna S, Lazzarin A, Di Perri G (2010)
Pharmacokinetics of Raltegravir, Etravirine and Maraviroc regimen in the clinical setting.
https://iris.unito.it/handle/2318/88283

A Yilmaz, C Verhofstede, A D?avolio, V Watson, L Hagberg, D Fuchs, B Svennerholm, M Gisslén (2010)
Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral Therapy.
https://iris.unito.it/handle/2318/81769

Marco Simiele, Antonio D?Avolio, Marco Siccardi, Lorena Baietto, Francesca Romana Stefani, Silvia Agati, Jessica Cusato, Mauro Sciandra, Stefano Bonora, Giovanni Di Perri (2010)
Are intracellular drug concentrations underestimated? The role of medium corpuscular volume (MCV) for a correct determination.
https://iris.unito.it/handle/2318/85705

A Calcagno, S Bonora, A D', Avolio, M Siccardi, M Simiele, M Chiesa, D G de Requena, G D Perri (2010)
Raltegravir penetration in seminal plasma of healthy volunteers.
https://iris.unito.it/handle/2318/81839

A D', Avolio, M Simiele, L Baietto, M Siccardi, M Sciandra, S Patanella, S Bonora, G D Perri (2010)
A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients.
https://iris.unito.it/handle/2318/81908

L Baietto, A D', Avolio, G Ventimiglia, F G De Rosa, M Siccardi, M Simiele, M Sciandra, G D Perri (2010)
Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.
https://iris.unito.it/handle/2318/81771

F G De Rosa, L Baietto, A D?Avolio, G Ventimiglia, M Siccardi, E Biasin, F Carraro, F Nesi, M Simiele, M Sciandra, G Di Perri (2010)
Prophylaxis drug monitoring of itraconazole and voriconazole in the paediatric onco-haematological setting.
https://iris.unito.it/handle/2318/107790

Silvia De Francia, Antonio D?Avolio, Francesca De Martino, Elisa Pirro, Francesca Maria Piccione, Silvia Racca, Francesco Di Carlo (2010)
New hplc-mass spectrometry method for the simultaneous quantification in human plasma of the antileukemia drugs imatinib, dasatinib, and nilotinib.
https://iris.unito.it/handle/2318/106189

Bonora S, D?Avolio A, Simiele M, Calcagno A, Baietto L, Chiesa M, Siccardi M, Gonzalez De Requena D, Sciandra M, Di Perri G (2010)
Steady-state Raltegravir Penetration in Seminal Plasma of Healthy Volunteers.
https://iris.unito.it/handle/2318/112826

A D?Avolio, M Siccardi, A Ciancio, L Baietto, M Simiele, S Patanella, D Aguilar Marucco, G Cariti, A Calcagno, M Sciandra, A Smedile, F G De Rosa, S Bonora, M Rizzetto, G Di Perri (2010)
SLC29A1 ?706G>C predict haemoglobin decrease in patients with hepatitis C treated with interferon and ribavirin.
https://iris.unito.it/handle/2318/107791

Silvia De Francia, Antonio D?Avolio, Lorena Baietto, Elisa Pirro, Francesca De Martino, Carmen Fava, Stefano Ulisciani, Giuseppe Saglio, Silvia Racca, Francesco Di Carlo (2010)
Role of cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use.
https://iris.unito.it/handle/2318/108495

Calcagno A, Milia MG, D', Avolio A, Ndayishimiyae P, Dusabimana P, Bonora S, Cusato J, Simiele M, Rostagno R, Siccardi M, Audagnotto S, Ghisetti V, Di Perri G (2010)
A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load.
https://iris.unito.it/handle/2318/110669

Siccardi M , D?Avolio A , Baietto L , Simiele M , Bonora S , Back D , Di Perri G , Owen A (2010)
SLCO3A1 expression is a major determinant of atazanavir PBMC penetration in HIV infected patients.
https://iris.unito.it/handle/2318/112033

Schipani A , Siccardi M , D', Avolio A , Baietto L , Bonora S , Davies G , Khoo S , Back D , Di Perri G , Owen A (2010)
Population pharmacokinetics of unboosted atazanavir and influence of the pregnane -x- receptor PXR 63396C > T.
https://iris.unito.it/handle/2318/111277

Bonora S, Calcagno A, Viganò O, Bigliano P, Rusconi S, Trentini L, Tettoni MC, Orofino G, Salassa B, Bramato C, D', Avolio A, Siccardi M, Colella E, Galli M, Di Perri G (2010)
Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting.
https://iris.unito.it/handle/2318/112827

Silvia De Francia, Antonio D', Avolio, Lorena Baietto, Elisa Pirro, Francesca De Martino, Carmen Fava, Stefano Ulisciani, Giuseppe Saglio, Silvia Racca, Francesco Di Carlo (2010)
Role of Cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use.
https://iris.unito.it/handle/2318/131236

Siccardi M, D', Avolio A, Simiele M, Sciandra M, Baietto L, Stefani F R, Agati S, Cusato J, Calcagno A, Owen A, Bonora S , Di Perri G (2010)
Intracellular Pharmacokinetics of Boosted and Unboosted Atazanavir in HIV Infected Patients.
https://iris.unito.it/handle/2318/112830

L Baietto, A D?Avolio, F G De Rosa, M Dominici, S Garazzino, M Siccardi, G Di Perri (2010)
Effect of multidrug-resistant gene polymorphisms on daptomycin concentrations: preliminary results.
https://iris.unito.it/handle/2318/107520

Andrea Calcagno, Stefano Bonora, Maria Cristina Tettoni, Antonio D', Avolio, Massimiliano Lanzafame, Giovanni Penco, Giovanni Di Perri (2009)
Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting.
https://iris.unito.it/handle/2318/71598

Calcagno A , Bonora S , Cometto C , Fontana S , Aguilar D , D', Avolio A , de Requena D Gonzalez, Maiello A , Sinicco A , Di Perri G (2009)
GREATER IMMUNOLOGICAL RECOVERY ASSOCIATED WITH ADDITIONAL ENFUVIRTIDE IN THE TREATMENT OF NAIVE HIV-INFECTED PATIENTS AT VERY ADVANCED DISEASE STAGES: 24-WEEK RESULTS OF A RANDOMIZED, CONTROLLED, PILOT STUDY.
https://iris.unito.it/handle/2318/93768

Baietto L, D', Avolio A, De Rosa FG, Michelazzo M, Garazzino S, Vizio L, Simiele M, Siccardi M, Di Perri G (2009)
Influenza dei polimorfismi C3453T, C1236T, G2677T/A del gene MDR1 sulle concentrazioni plasmatiche di daptomicina.
https://iris.unito.it/handle/2318/116007

Baietto L, D', Avolio A, De Rosa FG, Garazzino S, Siccardi M, Simiele M, Sciandra M, Salizzoni M, Di Perri G (2009)
Farmacocinetica della caspofungina in pazienti sottoposti a trapianto epatico.
https://iris.unito.it/handle/2318/116510

M Siccardi, A D?Avolio, S Nozza, S Bonora, A Castagna, L Baietto, F R Stefani, D Moss, A Calcagno, M Sciandra, A Lazzarin, D Back, A Owen, G Di Perri (2009)
Is Maraviroc a substrate for SLCO1B1?
https://iris.unito.it/handle/2318/69068

De Rosa FG, D', Avolio A, Baietto L, Pasero D, Montrucchio C, Urbino R, Siccardi M, Simiele M, Dominaci MC, Ventimiglia G, Salizzoni M, Di Perri G (2009)
Farmacocinetica dell?anidulafungina in pazienti con fibrosi cistica, trapianto epatico e emodiafiltrazione: dati preliminari.
https://iris.unito.it/handle/2318/112031

Gonzalez de Requena D, Bonora S, Cometto C, Magnani S, D', Avolio A, Milia M, Vigano', O, Di Garbo A, Calcagno A, Siccardi M, Baietto L, Sciandra M, Rusconi S, Di Perri G (2009)
Effect of Darunavir (DRV) genotypic inhibitory quotient (gIQ) on the virological response to DRV-containing salvage regimens at 24 weeks.
https://iris.unito.it/handle/2318/111483

D', AVOLIO ANTONIO (2009)
Farmacocinetica e TDM.
https://iris.unito.it/handle/2318/72430

Garazzino S, Aprato A, Baietto L, D', Avolio A, Maiello A, De Rosa FG, Aloj D, Siccardi M, Biasibetti A, Massè A, Di Perri G (2008)
Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.
https://iris.unito.it/handle/2318/62319

MAGGI P, FILOTICO R, BONORA S, VOLPE A, BELLACOSA C, CINORI E, DE REQUENA DG, D', AVOLIO A, DI PERRI G (2008)
Does Iatrogenic Scleroderma due to Injection-Site Reaction to Enfuvirtide Impair Absorption of the Drug?
https://iris.unito.it/handle/2318/27489

Daniel Gonzalez de, Stefano Bonora, Andrea Calcagno, Antonio D', Avolio, Marco Siccardi, Silvia Fontana, Maria Grazia Milia, Mauro Sciandra, Silvia Garazzino, Antonio Di Garbo, Lorena Baietto, Laura Trentini, Giovanni Di Perri (2008)
Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimens.
https://iris.unito.it/handle/2318/45038

Pauline Byakika-Kibwika, Mohammed Lamorde, Francis Kalemeera, Antonio D', Avolio, Sciandra Mauro, Giovanni Di Perri, Mairin Ryan, Harriet Mayanja-Kizza, Saye Khoo, David Back, Marta Boffito, Concepta Merry (2008)
Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults.
https://iris.unito.it/handle/2318/44913

Giovanni Guaraldi, Stefania Cocchi, Alice Motta, Sara Ciaffi, Mauro Codeluppi, Stefano Bonora, Fabrizio Di Benedetto, Michele Masetti, Marco Floridia, Silvia Baroncelli, Diego Pinetti, Antonio D', Avolio, Alfio Bertolini, Roberto Esposito (2008)
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease.
https://iris.unito.it/handle/2318/45890

Daniel Gonzalez de, Stefano Bonora, Antonella Castagna, Hamid Hasson, Diego Aguilar Marucco, Antonio D', Avolio, Mauro Sciandra, Laura Trentini, Andrea Calcagno, Adriano Lazzarin, Giovanni Di Perri (2008)
Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients.
https://iris.unito.it/handle/2318/44069

Antonio D?avolio, Lorena Baietto, Marco Siccardi, Mauro Sciandra, Marco Simiele, Valentina Oddone, Stefano Bonora, Giovanni Di Perri (2008)
An HPLC-PDA Method for the Simultaneous Quantification of the HIV Integrase Inhibitor Raltegravir, the New Nonnucleoside Reverse Transcriptase Inhibitor Etravirine, and 11 Other Antiretroviral Agents in the Plasma of HIV-Infected Patients.
https://iris.unito.it/handle/2318/48533

Bonora S, D', Avolio A, Tettoni C, Siccardi M, Gonzalez de Requena D, Baietto L, Cometto C, Sciandra M, Trentini L, Di Perri G (2008)
A pilot study evaluating plasma and intracellular pharmacokinetics (PK) of switching from atazanavir (ATV) 400mg QD to ATV 200 mg BID in HIV+ patients.
https://iris.unito.it/handle/2318/115583

S Garazzino, A Aprato, D Aloj, F G De Rosa, A D', Avolio, A Massé, G Di Perri (2007)
Antibiotic diffusion in pseudoarthrosic infected bone: glycopeptides, fluoroquinolones and carbapenems.
https://iris.unito.it/handle/2318/45558

A D', AVOLIO, M SICCARDI, M SCIANDRA, L BAIETTO, S BONORA, L TRENTINI, G DI PERRI (2007)
HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.
https://iris.unito.it/handle/2318/43075

BONORA S, CALCAGNO A, FONTANA S, D', AVOLIO A, SICCARDI M, GOBBI F, DI PERRI G (2007)
Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject.
https://iris.unito.it/handle/2318/38543

Garazzino S , De Rosa F G , D', Avolio A , Michelazzo M , Di Perri G (2007)
Clinical significance of pharmacokinetics of ertapenem in an outpatient setting.
https://iris.unito.it/handle/2318/117151

D', AVOLIO A, SCIANDRA M, DE REQUENA DG, IBANEZ A, BONORA S, DI PERRI G (2006)
An improved HPLC fluorimetric method for the determination of enfuvirtide plasma levels in HIV-infected patients.
https://iris.unito.it/handle/2318/42525

CANTA F, MARRONE R, BONORA S, D', AVOLIO A, SCIANDRA M, SINICCO A, DE ROSA FG, DI PERRI G (2005)
Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients.
https://iris.unito.it/handle/2318/39972

Boffito M , D', Avolio A , Di Perri G , Sciandra M , Bonora S , Back D , Hill A , Moyle G , Nelson M , Higgs C , Tomkins J , Gazzard B , Pozniak a (2004)
Repeated pharmacokinetics of tenofovir disoproxil fumarate in HIV-infected adults receiving saquinavir hard gel/ritonavir 1000/100 mg BID.
https://iris.unito.it/handle/2318/126611

Bonora S , Boffito M , D', Avolio A , Sciandra M , Aguilar D , Canta F , Maiello A , Lucchini A , Arnaudo I , Dav Conte I , Meoli I , Back D , Di Perri G (2003)
Pharmacokinetics (PKS) of rifabutin (RIF) coadministered with lopinavir/ritonavir (LPV/r) in HIV patients affected by tuberculosis (TB).
https://iris.unito.it/handle/2318/122519

BOSIO K, AVANZINI C, D', AVOLIO A, OZINO O, SAVOIA D (2000)
In vitro activity of propolis against Streptococcus pyogenes.
https://iris.unito.it/handle/2318/37441

BERTA GN, GHEZZO F, D', AVOLIO A, ZULIAN P, CARBONE V, RACCA S, VERCELLINO V, DI CARLO F (1997)
Enhancement of calcyclin gene RNA expression in squamous cell carcinoma of the oral mucosa, but not in benign lesions.
https://iris.unito.it/handle/2318/42160

Courses

• ADE Farmaci long-acting nell'ambito della terapia infettiva (SME0986)
  Laurea Magistrale in Medicina e Chirurgia - sede di Torino
• ADE Strategie di personalizzazione delle terapie farmacologiche (SME0885)
  Laurea Magistrale in Medicina e Chirurgia - sede di Torino
• C.I. TERAPIE BIOTECNOLOGICHE (SME0901)
  Corso di Laurea Magistrale in Biotecnologie Mediche - Classe LM-9
• FARMACOLOGIA CLINICA (MED3431C)
  Corso di Laurea in Infermieristica Pediatrica
• FARMACOLOGIA GENERALE (MED3164A)
  Corso di Laurea in Infermieristica Pediatrica
• Farmacologia II (Canale B) (SME0728)
  Laurea Magistrale in Medicina e Chirurgia - sede di Torino
• Farmacologia II (Canale C) (SME0728)
  Laurea Magistrale in Medicina e Chirurgia - sede di Torino
• Farmacologia II (Canale D) (SME0728)
  Laurea Magistrale in Medicina e Chirurgia - sede di Torino
• Farmacologia I (canale A) (SME0722)
  Laurea Magistrale in Medicina e Chirurgia - sede di Torino
• Farmacologia I (canale B) (SME0722)
  Laurea Magistrale in Medicina e Chirurgia - sede di Torino
• INFERMIERISTICA PEDIATRICA CLINICA (MED3164)
  Corso di Laurea in Infermieristica Pediatrica
• (OPZIONALE) FARMACOLOGIA GENERALE ( SME0761)
  Corso di Laurea Magistrale in Biotecnologie Mediche - Classe LM-9
• PROBLEMI DI SALUTE IN PEDIATRIA I (MED3431)
  Corso di Laurea in Infermieristica Pediatrica
• TIROCINIO di FARMACOLOGIA CLINICA E FARMACOGENOMICA (SME0913)
  Corso di Laurea Magistrale in Biotecnologie Mediche - Classe LM-9
• Terapie Biotecnologiche in Farmacologia (SME0901A)
  Corso di Laurea Magistrale in Biotecnologie Mediche - Classe LM-9

Research topics

Gruppi di ricerca

Farmacologia Clinica e Farmacogenetica

Research groups

• of Infectious Diseases

Research projects

• Multidisciplinary Assessment of the blood and gut-associated HIV Reservoir and Immunity following Switch from 3-drug to 2-drug Antiretroviral regimens in virologically suppressed patients
• Multidisciplinary Assessment of the blood and gut-associated HIV Reservoir and Immunity following Switch from 3-drug to 2-drug Antiretroviral regimens in virologically suppressed patients (MARISA)
• SARS-CoV-2 e non solo: portare fino alla sperimentazione umana un candidato farmaco antivirale pan-coronavirus. Thinking innovative to fight the unexpected

Activities in agenda

See my calendar

Academic bodies

• Junta

• Commissione Ricerca
• Consiglio

Office hours

Mercoledì 9:00-11:00, previo accordo telefonico (Tel. 011.4393979)